Nasdaq-Listed Cypherpunk Buys $29M In Zcash As Hayes Predicts $1,000 Target

Nasdaq-Listed Cypherpunk Buys $29M In Zcash As Hayes Predicts $1,000 Target

Nasdaq-listed Cypherpunk Technologies acquired 56,418 Zcash (ZEC) tokens for approximately $29 million on December 30.

The purchase brings the privacy-focused technology company's total holdings to 290,062.67 ZEC, representing an estimated 1.76% of the circulating supply.

Cypherpunk paid an average price of $514.02 per token for the latest acquisition.

The institutional buying comes as former BitMEX CEO Arthur Hayes predicts Zcash could reach $1,000, citing growing demand for privacy assets.

What Happened

Cypherpunk's cumulative Zcash position was acquired at an average price of $334.41 per token, according to the company's announcement.

Will McEvoy, CIO of Cypherpunk Technologies, stated the company continues executing on its goal of accumulating 5% of the Zcash network.

The purchase follows Zcash's slight rally since Hayes issued his $1,000 price target on December 29.

The token currently trades around $535.

Grayscale's Q4 2025 report identified Zcash as the top performer among privacy coins tracked by the investment firm.

Over 5 million ZEC tokens are now locked in shielded addresses, representing approximately 30% of circulating supply.

Read also: Precious Metals Surge 70-150% While Bitcoin Lags With 6% Annual Loss

Why It Matters

The institutional accumulation demonstrates growing corporate appetite for privacy-focused cryptocurrencies as regulatory scrutiny intensifies globally.

Zcash has gained over 800% year-to-date in 2025, significantly outperforming Bitcoin and Ethereum.

Cypherpunk's stated goal of accumulating 5% of the network supply signals long-term conviction in privacy technology adoption.

Hayes cited Zcash's November 2025 halving event as a supply inflection point that reduced token issuance and contracted available liquidity.

However, regulatory pressure on privacy coins remains a significant risk, with potential enforcement actions capable of driving prices substantially lower.

Cypherpunk Technologies also operates through subsidiary Leap Therapeutics, which develops cancer therapies.

Read next: Prediction Markets Projected To Hit $40B Volume In 2025 With 400% Growth Rate

Disclaimer and Risk Warning: The information provided in this article is for educational and informational purposes only and is based on the author's opinion. It does not constitute financial, investment, legal, or tax advice. Cryptocurrency assets are highly volatile and subject to high risk, including the risk of losing all or a substantial amount of your investment. Trading or holding crypto assets may not be suitable for all investors. The views expressed in this article are solely those of the author(s) and do not represent the official policy or position of Yellow, its founders, or its executives. Always conduct your own thorough research (D.Y.O.R.) and consult a licensed financial professional before making any investment decision.
Latest News
Show All News